(MENAFN Editorial) iCrowdNewswire - Aug 24, 2017
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain are some of the major symptoms of hepatitis B. Having a chronic HBV may lead to serious implications like liver cancer and liver failure.
Complete report available at .
Major Symptoms of Hepatitis B Virus: fever, fatigue, Headache, Loss of appetite, nausea, vomiting, Constant discomfort right side of the belly under the rib cage, an-colored bowel movements, Dark urine
Causes of Hepatitis B Virus (HBV) is passed from person to person through blood, semen or other body fluids. i.e. Sharing of needles, Sexual contact, Mother to child & Accidental needle sticks.
Keeping the threat in mind, many governments in the European countries and the US have made it mandatory for the people to go through the screening and proper monitoring since hepatitis B takes time to develop and is not easily recognizable. There are some curative therapies available but they are not very efficient. It is expected that many innovative therapies which have shown positive results in trials will occupy the market in the coming years. Many companies have products related to hepatitis B in their pipeline.
Purchase a copy of this 'Hepatitis B Virus (HBV) Market research report at USD 800 (Single User License) .
The key factors driving the growth of hepatitis B market are increase in liver cancer and cirrhosis deaths, increasing ageing population, increasing healthcare expenditure and urbanization leading to better monitoring and screening procedures. Some of the noteworthy trends and developments of this industry are new HBV treatments in development, government initiative and public awareness, collaboration, innovation and research, preference for biomarker based tests. However, the expansion of hepatitis B market is hindered by rigid competition, management challenges, lack of diagnostic facilities and high cost of medical care and legal regulations.
The report 'Global Hepatitis B Virus (HBV) Market 10 Year Demand Forecast (2016-2025) provides an in-depth analysis of the global market along with markets of the US and Europe. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises large players such as Arrowhead, Arbutus, Gilead and Johnson & Johnson. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth.
Explore more related reports on pharmaceuticals market at .
Tel: + 1 888 391 5441